Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains

Brain(2023)10.1093/brain/awad398Source: DataRank Database

Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains is a research paper published in Brain (2023). On theSindex it has a DataRank of 1.8. It has been cited 20 times, with 16 citing works in its 1-hop citation network.

N/A

1.8DataRank · unranked

Scored on demand from live citation data

Open Access20 citations · 16 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (37 grants)OA: greenTopics (23)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 25%Citation Network 75%

Base Score Contribution

0.457

From this paper's citation signal

Citation Network Contribution

1.4

From 11 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 16 citers.

IGFBP2 levels associated with Alzheimer disease
Nature Reviews Neurology20233 citations1 referencesContributes 1.386
Search for cerebrospinal fluid biomarkers in patients with major psychiatric disorders: Multiplex immunoassay findings and proximity extension assay prospects
Neuropsychopharmacology Reports202410 citations31 referencesContributes 0.077
Insulin‐Like Growth Factor Binding Protein 2 Drives Neurodegeneration in Parkinson's Disease: Insights From In Vivo and In Vitro Studies
CNS Neuroscience & Therapeutics20245 citations56 referencesContributes 0.032
The 15‐Year Survival Advantage: Immune Resilience as a Salutogenic Force in Healthy Aging
Aging Cell20259 citations77 referencesContributes 0.030
The IGF System and Aging
Endocrine Reviews202428 citations164 referencesContributes 0.021

Authors (89)

Anne Labonté ORCID,Cynthia Picard ORCID,Henrik Zetterberg ORCID,Kaj Blennow ORCID,Ann Brinkmalm ORCID

Live enrichment

PubMed:37992295 PMC:PMC11068109

Swedish Research Council

Grant: #2022-01018

Swedish Research Council

Grant: #2019-02397

Swedish Research Council

Grant: #2017-00915

Swedish Research Council

Grant: #2022-00732

European Union’s Horizon Europe

Grant: 101053962

Alzheimer Drug Discovery Foundation

Grant: #201809-2016862

Alzheimer’s Association

Grant: #ADSF-21-831376-C

Alzheimer’s Association

Grant: #ADSF-21-831381-C

Alzheimer’s Association

Grant: #ADSF-21-831377-C

Alzheimer’s Association

Grant: ZEN-21-848495

Alzheimer’s Association

Grant: SG-23-1038904

Marie Skłodowska-Curie

Grant: 860197

European Union Joint Programme—Neurodegenerative Disease Research

Grant: JPND2021-00694

UK Dementia Research Institute

Grant: UKDRI-1003

Swedish Alzheimer Foundation

Grant: #AF-930351

Swedish Alzheimer Foundation

Grant: #AF-939721

Swedish Alzheimer Foundation

Grant: #AF-968270

Hjärnfonden

Grant: #FO2022-0270

Hjärnfonden

Grant: #FO2017-0243

Hjärnfonden

Grant: #ALZ2022-0006

Hjärnfonden

Grant: #ALFGBG-715986

Hjärnfonden

Grant: #ALFGBG-965240

Hjärnfonden

Grant: JPND2019-466-236

NIA NIH HHS

Grant: P30 AG066518

NIA NIH HHS

Grant: P30 AG072947

Bluefield Project

Erling-Persson Family Foundation

Olav Thon Foundation

National Institute for Health and Care Research University College London Hospitals Biomedical Research Centre

Fonds de recherche du Québec-Santé

CIHR

JL Levesque Foundation.

Stiftelsen för Gamla Tjänarinnor

Wallenberg Scholar

McGill University

Canadian Institutes of Health Research

European Union’s Horizon 2020

greenLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

repositoryhttps://discovery.ucl.ac.uk/10182499/1/awad398.pdf

publisherhttps://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad398/57303274/awad398.pdf

publisherhttps://academic.oup.com/brain/article-pdf/147/5/1680/57397365/awad398.pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11068109/pdf/awad398.pdf

MeSH Terms

BrainHumansAlzheimer DiseaseDisease ProgressionInsulin-Like Growth Factor Binding Protein 2tau ProteinsMagnetic Resonance ImagingAutopsyCohort StudiesNeuropsychological TestsAgedAged, 80 and overMiddle AgedFemaleMaleAmyloid beta-PeptidesBiomarkers

Keywords

Cerebrospinal fluidInsulin-like growth factorAlzheimer's diseaseRbansPost-mortem Brain TissueInsulin-like Growth Factor-binding Protein-2